{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:51:23Z","timestamp":1790387483075,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0122660","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T18:32:33Z","timestamp":1427308353000},"page":"e0122660","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Pioglitazone Treatment Increases Survival and Prevents Body Weight Loss in Tumor\u2013Bearing Animals: Possible Anti-Cachectic Effect"],"prefix":"10.1371","volume":"10","author":[{"given":"M\u00e9rcia","family":"Beluzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney B.","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe S.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rog\u00e9rio A. L.","family":"Serti\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe O.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaltinaitis B.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e2mela","family":"Knobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio S.","family":"Shida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo X.","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia","family":"Seelaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio B.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel L.","family":"Batista Jr.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"K Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e29330","DOI":"10.1371\/journal.pone.0029330","article-title":"Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service","volume":"7","author":"HA Parsons","year":"2012","journal-title":"PLoS ONE"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000073337","article-title":"What we have learned about cachexia in gastrointestinal cancer","volume":"21","author":"JA Palesty","year":"2003","journal-title":"Dig Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/sj.bjc.6605665","article-title":"Adipose tissue pathways involved in weight loss of cancer cachexia","volume":"102","author":"I Dahlman","year":"2010","journal-title":"Br J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.1209418","article-title":"Medicine. Lipases in cachexia","volume":"333","author":"P Arner","year":"2011","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cncr.21013","article-title":"Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care\u2014correlations with food intake, metabolism, exercise capacity, and hormones","volume":"103","author":"M Fouladiun","year":"2005","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/cncr.23802","article-title":"Lipolysis\u2014not inflammation, cell death, or lipogenesis\u2014is involved in adipose tissue loss in cancer cachexia","volume":"113","author":"M Ryden","year":"2008","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"MJ Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6603360","article-title":"Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice","volume":"95","author":"C Bing","year":"2006","journal-title":"Br J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/JOE-12-0307","article-title":"Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia","volume":"215","author":"ML Batista Jr","year":"2012","journal-title":"J Endocrinol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ijc.24784","article-title":"Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice","volume":"126","author":"ML Asp","year":"2010","journal-title":"Int J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1043-2760(00)00306-4","article-title":"PPAR gamma and the treatment of insulin resistance","volume":"11","author":"JM Olefsky","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.lfs.2006.09.009","article-title":"Biochemical mechanism of insulin sensitization, lipid modulation and anti-atherogenic potential of PPAR \u03b1\/\u03b3 dual agonist: Ragaglitazar","volume":"80","author":"S Sharma","year":"2006","journal-title":"Life Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"E Elstner","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","first-page":"1","article-title":"Peroxisome proliferator-activated receptor gamma and cancers","volume":"9","author":"HP Koeffler","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.94.1.237","article-title":"Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor","volume":"94","author":"P Tontonoz","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1073\/pnas.96.7.3951","article-title":"Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma","volume":"96","author":"GD Demetri","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2006.07.2777","article-title":"Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes","volume":"25","author":"R Govindarajan","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2012.09.021","article-title":"Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties","volume":"697","author":"S Saha","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4161\/cbt.12.11.18134","article-title":"Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia","volume":"12","author":"ML Asp","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"ref21","first-page":"1037","article-title":"Studies on the lipid metabolism of Walker 256 tumour-bearing rats during the development of cancer cachexia","volume":"39","author":"MC Seelaender","year":"1996","journal-title":"Biochem Mol Biol Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00441-004-0987-2","article-title":"Adipose tissue in Walker 256 tumour-induced cachexia: possible association between decreased leptin concentration and mononuclear cell infiltration","volume":"318","author":"A Machado","year":"2004","journal-title":"Cell and Tissue Research"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00520-010-0972-0","article-title":"Animal models of the cancer anorexia-cachexia syndrome","volume":"19","author":"N Bennani-Baiti","year":"2011","journal-title":"Support Care Cancer"},{"key":"ref24","first-page":"375","article-title":"Metabolism of Isolated Fat Cells. I. Effects of Hormones on Glucose Metabolism and Lipolysis","volume":"239","author":"M Rodbell","year":"1964","journal-title":"J Biol Chem"},{"key":"ref25","first-page":"65","article-title":"Cellularity measurements","volume":"155","author":"M DiGirolamo","year":"2001","journal-title":"Methods Mol Biol"},{"key":"ref26","first-page":"E934","article-title":"Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats","volume":"275","author":"FB Lima","year":"1998","journal-title":"Am J Physiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"SK Das","year":"2011","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0149-2918(00)80078-8","article-title":"A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus","volume":"23","author":"J Chilcott","year":"2001","journal-title":"Clinical Therapeutics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1464-5491.1999.00023.x","article-title":"Thiazolidinediones: a new class of antidiabetic drugs","volume":"16","author":"C Day","year":"1999","journal-title":"Diabetic Medicine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0735-1097(03)00159-1","article-title":"Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure","volume":"41","author":"WH Tang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"AM Lincoff","year":"2007","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0026-0495(94)90173-2","article-title":"Regulation of glucose transport by pioglitazone in cultured muscle cells","volume":"43","author":"IM el-Kebbi","year":"1994","journal-title":"Metabolism"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.lfs.2010.08.002","article-title":"Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db\/db mice","volume":"87","author":"K-J Yang","year":"2010","journal-title":"Life Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jamda.2010.02.004","article-title":"Consensus on cachexia definitions","volume":"11","author":"JM Argiles","year":"2010","journal-title":"J Am Med Dir Assoc"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1210\/en.2011-0225","article-title":"PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells","volume":"152","author":"O Dubuisson","year":"2011","journal-title":"Endocrinology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cell.2011.09.050","article-title":"Adipocyte NCoR knockout decreases PPARgamma phosphorylation and enhances PPARgamma activity and insulin sensitivity","volume":"147","author":"P Li","year":"2011","journal-title":"Cell"},{"key":"ref37","first-page":"E1033","article-title":"Insulin secretion in Walker 256 tumor cachexia","volume":"258","author":"LC Fernandes","year":"1990","journal-title":"Am J Physiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1053\/meta.2000.9524","article-title":"Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa\/fa zucker rats: comparison to cl 316,243","volume":"49","author":"BF Burkey","year":"2000","journal-title":"Metabolism"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","article-title":"The role of insulin resistance in the development of muscle wasting during cancer cachexia","volume":"3","author":"MA Honors","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOG.0b013e3283347e77","article-title":"Cancer cachexia","volume":"26","author":"MJ Tisdale","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.molmed.2013.02.006","article-title":"The role of triglyceride lipases in cancer associated cachexia","volume":"19","author":"SK Das","year":"2013","journal-title":"Trends Mol Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cbf.2792","article-title":"Changes in blood metabolic parameters during the development of Walker-256 tumour-induced cachexia in rats are not caused by decreased food intake","volume":"30","author":"P Cassolla","year":"2012","journal-title":"Cell Biochem Funct"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1572-0241.2005.41690.x","article-title":"Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes","volume":"100","author":"N Chalasani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cyto.2012.10.023","article-title":"Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients","volume":"61","author":"ML Batista Jr.","year":"2013","journal-title":"Cytokine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/07315724.1992.10718249","article-title":"A review of cancer cachexia and abnormal glucose metabolism in humans with cancer","volume":"11","author":"JA Tayek","year":"1992","journal-title":"J Am Coll Nutr"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/978-1-4684-5643-1_95","article-title":"Blood flow, tissue oxygenation, pH distribution, and energy metabolism of murine mammary adenocarcinomas during growth","volume":"248","author":"P Vaupel","year":"1989","journal-title":"Adv Exp Med Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, Inflammation, and Insulin Resistance","volume":"132","author":"SE Shoelson","year":"2007","journal-title":"Gastroenterology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"83593","DOI":"10.1155\/2007\/83593","article-title":"'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies","volume":"2007","author":"M Gurnell","year":"2007","journal-title":"PPAR Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0122660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:54:01Z","timestamp":1589003641000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0122660"}},"subtitle":[],"editor":[{"given":"Fran\u00e7ois","family":"Blachier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0122660","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]}}}